
Welcome to the TIL Cell Therapy Working Group
The TlL Working Group is a team of internationally-recognized oncologists dedicated to helping healthcare practitioners better understand TIL cell therapy. TIL cell therapy is a type of cell therapy in which tumor-infiltrating lymphocytes are harvested from a patient’s tumor and grown in large numbers in vitro. These lymphocytes are then given back to the patient by infusion to help the immune system recognize and eliminate cancer cells.
Menu

TIL Cell Therapy Overview
TIL cell therapy is the autologous transfer of tumor-infiltrating lymphocytes obtained from a patient’s tumor. Learn more about the mechanism of action of TIL cell therapy and the components of this novel cell therapy.
- Immunology Background
- Evolution of Immunotherapy
- TIL Cell Therapy Mechanism
- TIL Cell Therapy Clinical Data
- Requirements for Delivery
- Summary
- Backup



















Previous
Next
Previous
Next
Previous
Next
Previous
Next
Previous
Next
Previous
Next
Tumor Resection
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.


TIL Production
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.
TIL Infusion
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.


Lymphodepletion
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.
IL-2 Treatment
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.

IL-2 Treatment
A short course of high-dose IL-2 is administered after TIL infusion to support T-cell activity. Learn more about best practices in IL-2 treatment as part of TIL cell therapy.

- Role of IL-2 in TIL Cell Therapy
- IL-2 Management
- Patient Case Studies





Previous
Next
Previous
Next
Contact Us
For more information about TIL cell therapy or the TIL Working Group, contact us using the form below.